London, United Kingdom

Garth Rapeport

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Garth Rapeport: Innovator in Mycoses Treatment

Introduction

Garth Rapeport is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mycoses. With a total of 11 patents to his name, Rapeport has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents is a process for preparing a compound useful to treat mycoses. This patent details a combination therapy that includes one or more compounds of a specific formula. The formula includes various chemical representations, such as R representing hydrogen, halo, cyano, and other groups. Another significant patent involves a process for preparing a compound of a different formula, which includes reacting specific compounds to achieve the desired therapeutic effect.

Career Highlights

Throughout his career, Garth Rapeport has worked with companies such as Pulmocide Limited and Plumocide Limited. His work in these organizations has contributed to advancements in the treatment of fungal infections, showcasing his dedication to improving patient outcomes.

Collaborations

Rapeport has collaborated with notable individuals in his field, including Thomas Christopher Colley and Kazuhiro Ito. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical industry.

Conclusion

Garth Rapeport's contributions to the field of mycoses treatment through his patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective therapies for fungal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…